Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial
Stanley Cohen, Robin K. Dore, Nancy E. Lane, et al.·2008·Arthritis & Rheumatism